These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 27325460)

  • 41. Regulation of myostatin expression and myoblast differentiation by FoxO and SMAD transcription factors.
    Allen DL; Unterman TG
    Am J Physiol Cell Physiol; 2007 Jan; 292(1):C188-99. PubMed ID: 16885393
    [TBL] [Abstract][Full Text] [Related]  

  • 42. aPKC alters the TGFβ response in NSCLC cells through both Smad-dependent and Smad-independent pathways.
    Gunaratne A; Chan E; El-Chabib TH; Carter D; Di Guglielmo GM
    J Cell Sci; 2015 Feb; 128(3):487–98. PubMed ID: 25501807
    [TBL] [Abstract][Full Text] [Related]  

  • 43. cDNA cloning and expression analysis of myostatin/GDF11 in shrimp, Litopenaeus vannamei.
    Qian Z; Mi X; Wang X; He S; Liu Y; Hou F; Liu Q; Liu X
    Comp Biochem Physiol A Mol Integr Physiol; 2013 May; 165(1):30-9. PubMed ID: 23402749
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibitors of the TGF-beta superfamily and their clinical applications.
    Tsuchida K; Sunada Y; Noji S; Murakami T; Uezumi A; Nakatani M
    Mini Rev Med Chem; 2006 Nov; 6(11):1255-61. PubMed ID: 17100637
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Loss of myostatin expression alters fiber-type distribution and expression of myosin heavy chain isoforms in slow- and fast-type skeletal muscle.
    Girgenrath S; Song K; Whittemore LA
    Muscle Nerve; 2005 Jan; 31(1):34-40. PubMed ID: 15468312
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Disruption of postnatal folliculogenesis and development of ovarian tumor in a mouse model with aberrant transforming growth factor beta signaling.
    Gao Y; Fang X; Vincent DF; Threadgill DW; Bartholin L; Li Q
    Reprod Biol Endocrinol; 2017 Dec; 15(1):94. PubMed ID: 29221447
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Notch-regulation upon Dll4-stimulation of TGFb-induced apoptosis and gene expression in human B-cell non-Hodgkin lymphomas.
    Hajdu M; Kopper L; Sebestyén A
    Scand J Immunol; 2010 Jan; 71(1):29-37. PubMed ID: 20017807
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibitory SMADs: potential regulators of ovarian function.
    Li Q
    Biol Reprod; 2015 Feb; 92(2):50. PubMed ID: 25550343
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Myostatin is an inhibitor of myogenic differentiation.
    Ríos R; Carneiro I; Arce VM; Devesa J
    Am J Physiol Cell Physiol; 2002 May; 282(5):C993-9. PubMed ID: 11940514
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Signal transduction pathway through activin receptors as a therapeutic target of musculoskeletal diseases and cancer.
    Tsuchida K; Nakatani M; Uezumi A; Murakami T; Cui X
    Endocr J; 2008 Mar; 55(1):11-21. PubMed ID: 17878607
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeting myostatin for therapies against muscle-wasting disorders.
    Tsuchida K
    Curr Opin Drug Discov Devel; 2008 Jul; 11(4):487-94. PubMed ID: 18600566
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transforming growth factor-beta1 upregulates myostatin expression in mouse C2C12 myoblasts.
    Budasz-Rwiderska M; Jank M; Motyl T
    J Physiol Pharmacol; 2005 Jun; 56 Suppl 3():195-214. PubMed ID: 16077203
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transgenic expression of a myostatin inhibitor derived from follistatin increases skeletal muscle mass and ameliorates dystrophic pathology in mdx mice.
    Nakatani M; Takehara Y; Sugino H; Matsumoto M; Hashimoto O; Hasegawa Y; Murakami T; Uezumi A; Takeda S; Noji S; Sunada Y; Tsuchida K
    FASEB J; 2008 Feb; 22(2):477-87. PubMed ID: 17893249
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quadrupling muscle mass in mice by targeting TGF-beta signaling pathways.
    Lee SJ
    PLoS One; 2007 Aug; 2(8):e789. PubMed ID: 17726519
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transforming growth factor-beta and myostatin signaling in skeletal muscle.
    Kollias HD; McDermott JC
    J Appl Physiol (1985); 2008 Mar; 104(3):579-87. PubMed ID: 18032576
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of the minimum region of flatfish myostatin propeptide (Pep45-65) for myostatin inhibition and its potential to enhance muscle growth and performance in animals.
    Kim JH; Kim JH; Sutikno LA; Lee SB; Jin DH; Hong YK; Kim YS; Jin HJ
    PLoS One; 2019; 14(4):e0215298. PubMed ID: 30998775
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of myostatin and bone morphogenetic proteins in muscular disorders.
    Tsuchida K
    Expert Opin Biol Ther; 2006 Feb; 6(2):147-54. PubMed ID: 16436040
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endoplasmic reticulum stress induces myostatin precursor protein and NF-kappaB in cultured human muscle fibers: relevance to inclusion body myositis.
    Nogalska A; Wojcik S; Engel WK; McFerrin J; Askanas V
    Exp Neurol; 2007 Apr; 204(2):610-8. PubMed ID: 17261282
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structural basis for potency differences between GDF8 and GDF11.
    Walker RG; Czepnik M; Goebel EJ; McCoy JC; Vujic A; Cho M; Oh J; Aykul S; Walton KL; Schang G; Bernard DJ; Hinck AP; Harrison CA; Martinez-Hackert E; Wagers AJ; Lee RT; Thompson TB
    BMC Biol; 2017 Mar; 15(1):19. PubMed ID: 28257634
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of TGF-β, inhibin βA and follistatin paralogs in the rainbow trout genome.
    de Mello F; Streit DP; Sabin N; Gabillard JC
    Comp Biochem Physiol B Biochem Mol Biol; 2014; 177-178():46-55. PubMed ID: 25149133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.